Summary of project PR001709

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001709. The data can be accessed directly via it's Project DOI: 10.21228/M8ST56 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR001709
Project DOI:doi: 10.21228/M8ST56
Project Title:Fibroblast growth factor-21 treatment induces skeletal muscle atrophy and increases plasma amino acids in female mice: a potential role for glucocorticoids.
Project Type:Untargeted metabolomics
Project Summary:We analyzed untargeted 'primary metabolites' (carbohydrates and sugar phosphates, amino acids, hydroxyl acids, free fatty acids, purines, pyrimidines, aromatics, exposome-derived chemicals) in plasma from high fat diet-fed (60% kcal, Research Diets Cat# D12492) DIO male and female mice treated for 12 days with FGF21 (0.2mg/kg/d, i.p.) or saline (n=11-13/group).
Institute:University of California, Davis
Department:Neurobiology, Physiology and Behavior
Laboratory:Dr. Karen K. Ryan
Last Name:Goodson
First Name:Michael
Address:SVM APC, 1 Shields Ave. Davis, CA 95616
Email:mlgoodson@ucdavis.edu
Phone:530.602.9969
Funding Source:NIH NIDDK
Contributors:Karen K. Ryan, Karl Larsen, Michael L. Goodson

Summary of all studies in project PR001709

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST002746 Fibroblast growth factor-21 treatment induces skeletal muscle atrophy and increases plasma amino acids in female mice: a potential role for glucocorticoids. Mus musculus University of California, Davis MS 2025-06-02 1 47 Uploaded data (462.3M)*
  logo